Abstract:Background: At present, the commercial artificial small diameter (< 6 mm) vascular grafts are still unsatisfactory, due to poor biocompatibility and low long-term patency rate. Objective: This study was to design a novel tissue engineering blood vessel constructed by dog bone marrow derived endothelial progenitor cells and decellularized allogeneic vascular scaffolds. Design, time and setting: From December 2005 to December 2007, the experiment, a randomized control trial of cells an histopathology in vitro, was completed in the Affiliated Drum Tower Hospital of Nanjing University Medical School. Materials: The decellularized canine common carotids were obtained by a detergent-enzymatic procedure; Bone marrow mononuclear cells from mongrel adult dogs were isolated using density gradient centrifugation method and cultured in culture flasks coated with fibronectin. Subsequently, the expanded endothelial progenitor cells were seeded on the decellularized scaffolds, and then co-cultured in the self-made bioreactor to construct the tissue engineering blood vessels. Methods: Bilateral common carotid artery and lateral femoral artery in twenty dogs were all exposed. Three vascular segments from each dog were harvested and then randomly divided into three groups according to the transplant with the tissue engineering blood vessels, decellularized allogeneic vascular scaffolds or autogenous vein. Twenty vessels were implanted into the dogs of each group. Main outcome measures: Immunocytochemical staining was used to identify the cultured endothelial progenitor cells; After 6 months of transplantation, the grafts were retrieved for digital subtraction angiography, pathological test and scanning electron microscope examination. Results: Dog bone marrow mononuclear cells presented a cobblestone-like appearance at 10 days of the culture. The immunocytochemistry results were consistent with the phenotype of endothelial progenitor cells; After highly proliferative endothelial progenitor cells were seeded onto the decellularized scaffold for 10 days, seed cells attached well in the lumen of blood vessels; Six months after implantation, the tissue engineering blood vessels were 85% patent and autogenous vein grafts were 90 patent, which was superior to decellularized allogeneic vascular scaffolds (25%). Conclusion: This study provides a new strategy to develop a tissue engineering blood vessel with excellent biocompatibility and high patency rate by the co-culture of dog bone marrow derived endothelial progenitor cells with decellularized vascular scaffolds.

[Constructing a Small-Diameter Decellularized Vascular Graft Pre-Loaded with Bfgf].

Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor.

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

A New Method of Making Arterious Acellular Scaffold

Tissue Engineering of Small-Diameter Vascular Grafts by Endothelial Progenitor Cells Seeding Heparin-Coated Decellularized Scaffolds.

Constructing small-caliber anticoagulant vascular grafts using decellularized scaffolds with heparin immobilization

Tissue-engineered blood vessels constructed by bone marrow-derived endothelial progenitor cells and decellularized vascular scafflolds

Design, Preparation, and Performance of a Novel Bilayer Tissue-Engineered Small-Diameter Vascular Graft.

Engineered Vascular Graft Using Nanoscale Decellularized Arteries Modified with Controlled-Release Heparin and Vascular Endothelial Growth Factor

Preliminary Study of in Vitro Construction of Small-Diameter Vascular Graft by Seeding Cells Onto Decellullarized Arterial Matrix

Beneficial Effects Of Granulocyte-Colony Stimulating Factor On Small-Diameter Heparin Immobilized Decellularized Vascular Graft

Performance of a multilayered small-diameter vascular scaffold dual-loaded with VEGF and PDGF.

Development And In Vivo Evaluation Of Small-Diameter Vascular Grafts Engineered By Outgrowth Endothelial Cells And Electrospun Chitosan/Poly(Epsilon-Caprolactone) Nanofibrous Scaffolds

Design and Preparation of Polyurethane-Collagen/heparin-conjugated Polycaprolactone Double-Layer Bionic Small-Diameter Vascular Graft and Its Preliminary Animal Tests.

Endothelialization and Patency of Rgd-Functionalized Vascular Grafts in A Rabbit Carotid Artery Model

Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization

The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.

Nanofibrous Vascular Scaffold Prepared from Miscible Polymer Blend with Heparin/stromal Cell-Derived Factor-1 Alpha for Enhancing Anticoagulation and Endothelialization

In vitro and in vivo evaluation of a novel collagen/cellulose nanocrystals scaffold for achieving the sustained release of basic fibroblast growth factor

Hydrogel-complexed Small-Diameter Vascular Graft Loaded with Tissue-Specific Vascular Extracellular Matrix Components Used for Tissue Engineering.

Successful Application of Biodegradable Vascular Scaffolds in the Dog Femoral Artery Transplantation